vialroom
Fortnightly digest · 2024-09-23 → 2024-10-06

the kidney result, read properly, by people who read it properly

A major renal outcome trial published this year finally got a careful reading rather than a headline. The channel that did it was bloodwork rather than semaglutide, which tells you something about where the room keeps its rigour. Two members with reduced kidney function had questions that nobody in a chat room can answer, and were told exactly that, kindly.

1.6Kmessages
78day logs
3channels noted
5notes

What happened

  • FLOW in NEJM 2024 was read for what it studied and what it did not, and the distinction between a trial population and a chat room was made explicitly.
  • eGFR trajectory rather than a single reading was the point several members had been missing when comparing results a year apart.
  • Nobody in the channel pretended a renal endpoint in a monitored trial translates into a recommendation for a member with existing disease.
  • The baseline panel pin was updated to make the renal function line harder to skip past, which it had been for about eight months.
  • A member with an isolated raised lipase was talked through what that does and does not indicate, with the red-flag symptom list restated in full.

Channels this fortnight

Most-reacted messages in this fortnight

Pulled from the logs, not hand-picked. Each links to the exact message.

Busiest logs in this fortnight

Topics touched